Petros Karakousis, MD
Enriched profileProfessor of Medicine · Johns Hopkins University School of Medicine
Petros Karakousis is Professor of Medicine at Johns Hopkins University School of Medicine. OpenAlex indexes 197 publications with 7,146 citations (h-index 47); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 18 Oct 2026
Petros Karakousis, M.D., is Professor of Medicine at Johns Hopkins University School of Medicine. The public record shows 197 publications with 7,146 citations (h-index 47), centered on Tuberculosis Research and Epidemiology, Infectious Diseases and Tuberculosis, Mycobacterium research and diagnosis. It also documents an investigator role on 1 registered clinical trials, 14 NIH-funded awards (2005–2026).
- Most recent indexed publication: 2026 · The Journal of infectious diseases
- Top research focus: Tuberculosis Research and Epidemiology
- 1 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 122.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
40.3%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor19.4%Triumeq53%Descovy47%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor14.3%Tivicay100%Part D≥12 patients+ 1 more class in this area
Cardiovascular
38.6%Statin18.6%Atorvastatin Calcium100%Part D≥13 patientsCalcium channel blocker6.9%Amlodipine Besylate54%Nifedipine Er46%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
9.4%DPP-4 inhibitor6.3%Januvia100%Part D<11 patientsGLP-1 receptor agonist3.1%Rybelsus100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
14 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- JHU TRAC: Training and Supporting the Next Generation of TB Researchers
Johns Hopkins University
FY2026$980,676P30AI168436 - Advancing Apoptosis-Inducing Agents as Host-Directed Therapy for TB
Johns Hopkins University
FY2025$2,922,220R01AI186308
Congress activity
Updated 18 Oct 2026
2 congress contributions (2020–2022) across AACR per OpenAlex. The most recent:
- Abstract LB531: The addition of IFNα and 5-Aza-2'deoxycytidine treatments to a dendritic cell-targeting DNA vaccine enhance the expression of Th1-related genes and the infiltration of CD11c+ CD8+ T-cells
AACR (meeting unresolved)
AACR2022Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The Phosphate-Specific Transport System Gene pstA1 Contributes to Rifampin Tolerance in Mycobacterium tuberculosis.
The Journal of infectious diseases
Article2026 - Discovery of highly potent α-keto ester-based peptidomimetic inhibitors of the Hip1 protease for the treatment of Mycobacterium tuberculosis.
European journal of medicinal chemistry reports
Article2025 - A Pivotal Trial in the Decline of Tuberculosis Sanatoria.
The Journal of infectious diseases
Comment2025 - When Infection Control Practices and Democracy Collide: Reply to Paladino and Riva.
The Journal of infectious diseases
Comment2025 - Pharmacologic Inhibition of Macrophage Triglyceride Biosynthesis Pathways Does Not Improve Mycobacterium tuberculosis Control in Infected Mice.
The Journal of infectious diseases
Article2025
Most-cited works
by citation count (OpenAlex)- 01Latent Tuberculosis Infection: Myths, Models, and Molecular MechanismsReview247 citations2014
- 02
- 03
- 04
- 05Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13Article184 citations2017
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/petros-karakousis-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
karakousislab.com
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →karakousislab.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Editorial & leadership roles
journal and society appointments- Editorial Board member
Journal of Infectious Diseases
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Academic Editor
PLoS One
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Working Group on New TB Drugs
Stop TB Partnership
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗ - Member
American Thoracic Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Member
American Society for Microbiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Member
Infectious Diseases Society of America
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Member
American College of Physicians
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Secondary affiliations
appointments beyond the home institution- Joint appointment
Molecular Microbiology & Immunology, Johns Hopkins Bloomberg School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Joint appointment
International Health, Johns Hopkins Bloomberg School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Principal Investigator
Johns Hopkins TB Research Advancement Center (TRAC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Kenneth Pienta, MD
Johns Hopkins University School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Harry Quigley, MD
Johns Hopkins University School of Medicine
Paul Ridker, MD
Brigham and Women's Hospital
Edward Giovannucci, MD, ScD, MPH
Harvard T.H. Chan School of Public Health
Stephen Chanock, MD
National Cancer Institute (NCI)
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center